Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
- 24 April 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 78, 400-402
- https://doi.org/10.1016/j.jocn.2020.04.107
Abstract
No abstract availableKeywords
Funding Information
- Hong Kong Research Grants Council
This publication has 5 references indexed in Scilit:
- Organoids in cancer researchNature Reviews Cancer, 2018
- Role of P-Glycoprotein on the Brain Penetration and Brain Pharmacodynamic Activity of the MEK Inhibitor CobimetinibMolecular Pharmaceutics, 2014
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell linesCancer Cell, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005